@article{ref1,
title="Use of phenothiazines as sedatives in children: what are the risks?",
journal="Drug safety",
year="1999",
author="Dyer, K. S. and Woolf, A. D.",
volume="21",
number="2",
pages="81-90",
abstract="Phenothiazines have been widely used for their antiemetic, antipsychotic and sedative properties for many years. The introduction of alternative agents for paediatric sedation has led to the re-evaluation of phenothiazines as paediatric sedatives. Newer agents, such as fentanyl and midazolam, have short half-lives and reversal agents are available. Therefore these agents may offer comparable therapeutic efficacy with a better safety profile in young children. Reports of sudden infant death syndrome in children receiving a phenothiazine-containing syrup for symptoms of upper respiratory infection means that the outpatient use of these compounds in very young infants is not recommended.<p /><p>Language: en</p>",
language="en",
issn="0114-5916",
doi="",
url="http://dx.doi.org/"
}